Khurram Jamil Galectin Therapeutics Inc (GALT) insider trading activity

GALT Quotes by TradingView

Khurram Jamil is Chief Medical Officer of GALECTIN THERAPEUTICS INC. Currently has a direct ownership of 0 shares of GALT, which is worth approximately $0. The most recent transaction as insider was on Dec 17, 2025, when has been sold 19,442 shares (Common Stock) at a price of $7.04 per share, resulting in proceeds of $136,871. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Khurram Jamil Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 17 2025
SELL
Open market or private sale
$136,871 $7.04 p/Share
19,442 Reduced 100.0%
0 Common Stock
Dec 17 2025
BUY
Exercise of conversion of derivative security
$35,163 $2.35 p/Share
14,963 Added 63.77%
8,500 Common Stock
Nov 13 2025
SELL
Open market or private sale
$662,509 $5.47 p/Share
121,117 Reduced 96.43%
4,479 Common Stock
Nov 13 2025
BUY
Exercise of conversion of derivative security
$196,515 $1.98 p/Share
99,250 Added 82.72%
20,729 Common Stock
Dec 23 2024
SELL
Open market or private sale
$12,015 $0.88 p/Share
13,654 Reduced 34.14%
26,346 Common Stock
Dec 23 2024
BUY
Exercise of conversion of derivative security
-
40,000 Added 50.0%
40,000 Common Stock
KJ

Khurram Jamil

Chief Medical Officer
Newtown, PA

Track Institutional and Insider Activities on GALT

Follow GALECTIN THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GALT shares.

Notify only if

Insider Trading

Get notified when an Galectin Therapeutics Inc insider buys or sells GALT shares.

Notify only if

News

Receive news related to GALECTIN THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GALT